T1	Participants 105 142	polycystic ovarian syndrome patients.
T2	Participants 339 383	polycystic ovarian syndrome (PCOS) patients.
T3	Participants 435 524	patients with PCOS undergoing controlled ovarian hyperstimulation (COH) with GnRH agonist
T4	Participants 718 784	112 infertile PCOS patients entering assisted reproduction cycles.
